Panacea Biotec on July 4, 2021, received its licence from the Drugs Controller General of India (DCGI) to manufacture Sputnik V COVID-19 vaccine at its facility in Baddi, Himachal Pradesh.In a statement by Panacea Biotec, it said, “The licence is a necessary condition for using Sputnik V produced by Panacea Biotech in India.”